Drug resistance in pancreatic cancer: Scientists pinpoint major and minor signaling pathways that drive it
Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites seeding new resistant tumors elsewhere in the body.
Combating the problem has become the singular enterprise of some cancer research laboratories, which have been seeking the myriad causes of drug resistance and searching for methods to thwart them.
At the University of Virginia in Charlottesville, scientists who had been searching for elusive signaling pathways that underpin drug resistance in pancreatic ductal adenocarcinoma not only found them, but traced them to another molecular mechanism that insidiously sustains drug resistance.
As scientific sleuths, the team relied on information theory, a branch of applied mathematics, to aid their hunt for errant molecules that help drive drug resistance in cancer.
Pancreatic ductal adenocarcinoma is the most common form of the disease, affecting up to 90% of people diagnosed with the cancer, according to the U.S. National Institutes of Health.
The cancer is also extraordinarily difficult to treat because of its usually late-stage diagnosis and treatment obstacles stemming from drug resistance, which impact patients no matter where they are undergoing therapy around the globe.
Event Name : International Molecular Biologist Awards
Website Link: molecularbiologist.org/
Contact Mail ID : support@molecularbiologist.org
Nomination Link : https://molecularbiologist.org/award-nomination/?ecategory=Awards&rcategory=Awardee
Follow On:
Twitterhttps://x.com/Camilla532645
Blogger https://molecularconference.blogspot.com/
Youtube https://www.youtube.com/channel/UCehrwFGWKbQa0mKDDNJCwvA
Pinterest https://in.pinterest.com/molecularbiologistawards/
Linkedin https://www.linkedin.com/feed/?trk=onboarding-landing
Instagram https://www.instagram.com/molecularawards

Comments
Post a Comment